Related Experiment Video
Updated: Jun 10, 2026
14:51
Comprehensive Workflow of Mass Spectrometry-based Shotgun Proteomics of Tissue Samples
Published on: November 13, 2021
Stability comparison between sample preparation procedures for mass spectrometry-based targeted or shotgun peptidomic
1Groupe de recherche en pharmacologie animal du Québec (GREPAQ), Département de biomédecine vétérinaire, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada J2S 2M2. francis.beaudry@umontreal.ca
Analytical Biochemistry
|August 24, 2010
Summary
Neuropeptide stability is crucial for drug development. Homogenizing spinal cord tissue in 0.25% trifluoroacetic acid stabilizes key neuropeptides, unlike PBS or protease inhibitor buffers, ensuring accurate quantification.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Neuropeptide quantification is vital for developing drugs targeting central nervous system (CNS) functions.
- Accurate measurement of neuropeptides requires precise methods and stable samples.
- Sample stability is a critical, yet often overlooked, factor in neuropeptide analysis.
Purpose of the Study:
- To compare the stability of neuropeptides across different sample preparation protocols.
- To identify optimal conditions for preserving neuropeptide integrity in spinal cord tissue.
- To inform best practices for neuropeptide quantification in CNS research and drug discovery.
Main Methods:
- Spinal cord tissues were homogenized using three distinct protocols.
- Phosphate-buffered saline (PBS) buffer was used as one homogenization medium.
- PBS buffer with a mammalian protease inhibitor cocktail was another medium.
- A 0.25% trifluoroacetic acid (TFA) solution was employed as the third homogenization medium.
- The stability of substance P, dynorphin A, and calcitonin gene-related peptide (CGRP) was assessed over time under standard laboratory conditions.
Main Results:
- Neuropeptide concentrations, including substance P, dynorphin A, and CGRP, showed significant degradation over time when homogenized in PBS buffer.
- The presence of a mammalian protease inhibitor cocktail in PBS buffer did not prevent neuropeptide degradation.
- Homogenization in 0.25% trifluoroacetic acid (TFA) effectively stabilized the concentrations of substance P, dynorphin A, and CGRP.
- TFA solution provided superior sample stability compared to PBS-based methods for these neuropeptides.
Conclusions:
- The choice of homogenization buffer significantly impacts neuropeptide stability in spinal cord tissue.
- 0.25% trifluoroacetic acid is a superior solution for preserving neuropeptide integrity during sample preparation.
- Optimized sample preparation protocols are essential for reliable neuropeptide quantification in CNS drug development.
